Expanse Medical Opens Providence Facility with Support from Rhode Island Life Science Hub
Expanse Medical announced it will open a new facility in Providence, Rhode Island, with support from the Rhode Island Life Science Hub, according to a press release. The new site will serve as the company’s East Coast base and as the launchpad for Valorian Medical Technologies, a new venture focused on men’s health innovation.
The Providence facility will connect engineering talent, clinicians, and investors, contributing to Rhode Island’s growing life sciences community. Valorian will leverage Expanse’s product development and clinical capabilities to develop medical technologies addressing men’s health conditions, including erectile dysfunction.
The expansion follows the launch of FlowPhysix, another Expanse portfolio company based in Austin, Texas, which commercialized the FDA-cleared FLOWRUNNER Aspiration System for treating blood clots. Expanse’s new Providence presence aims to strengthen collaboration with innovators and accelerate medical device development across the East Coast.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 17 Masimo Gets FDA Clearance for AFib Detection on Radius VSM Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform
HealthpointCapital Invests in Surgical Software Company Ospitek
Deep Longevity to Launch Accrua Telehealth Platform in US
Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub
Manhattan Physician Invests in RunPractice
Daily AI Brief: the AI news that matters, in your inbox.